No clear relationship between the levels of IGF-1 or GH and tumor development could be demonstrated, but certain risk factors, such as diabetes mellitus (DM) and obesity, were more frequent in patients with tumors. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.